"
Contribution to the Study of Resistance to Anti-Tuberculosis Drugs in the Mycobacterium tuberculosis Complex Isolated at the National Laboratory of Clinical Biology and Public Health in Bangui in the Central African Republic in 2022: Case of Rifampicin"
written by Clotaire Donatien Rafaï, Max Namzeka, Ernest Lango-Yaya, Romaric Oscar Tibet Kada, Oscar Senzongo Ndimakamoko, Serge Henri Gbazi, Le Bon Bondom, Christian Maucler Pamatika, Boniface Koffi, Alain Le Faou,
published by
Journal of Tuberculosis Research,
Vol.11 No.4, 2023
has been cited by the following article(s):